Consequently, increased MEK1/2 and p38 may increase IFN-γ production which in turn may desensitise K562 cells against NK cell cytotoxic activity in CFS/ME patients. The gene discussed is MAP2K1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.